Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase

Pediatric Blood & Cancer
Yvonne ArvidssonKeiko Funa

Abstract

Neuroblastoma is derived from cells of neural crest origin and often expresses the transcription factor human achaete-scute homolog 1 (HASH1). The aim of this study was to selectively kill neuroblastoma cells by expressing the suicide gene E. coli purine nucleoside phosphorylase (PNP) under the control of the Mash1 promoter, the murine homolog of HASH1. The E. coli PNP gene regulated by the Mash1 promoter was cloned into an expression vector and transfected into neuroblastoma and non-neuroblastoma cell lines. After addition of the prodrug M2-fluoroadenine 9-beta-D-arabinofuranoside (F-araA) the cell-specific toxicity was examined. To optimize the cell specific activity, different sizes of the Mash1 promoter were analyzed in neuroblastoma cell lines and compared with the activity in non-neuroblastoma cells. Estimated as the percentages of CMV enhancer-promoter, the activity was significantly higher in the neuroblastoma cells, ranging from 17 to 58% when the shortest and the most active promoter was measured. The non-neuroblastoma cells yielded only 1-6% of the CMV promoter activity. When the shortest Mash1 promoter was combined with the E. coli PNP gene the cytotoxicity was 65% in the neuroblastoma cells with low cell death in t...Continue Reading

References

Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D W BallB D Nelkin
Dec 1, 1995·Neuron·L SommerD J Anderson
Dec 15, 1996·Developmental Biology·S Verma-KurvariJ E Johnson
Oct 10, 1997·Human Gene Therapy·W B ParkerE J Sorscher
Jun 13, 1998·Developmental Biology·S Verma-KurvariJ E Johnson
Jun 20, 1998·Biochemical Pharmacology·W B ParkerL L Bennett
Jul 25, 1998·Science·E M Blackwood, J T Kadonaga
Mar 19, 1999·Biochemical and Biophysical Research Communications·H SöderholmS Påhlman
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L MohrJ R Wands
Jun 6, 2000·Developmental Biology·A Meredith, J E Johnson
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·D BalickiH N Lode
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ShabatC F Barbas
Aug 21, 2001·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·T TeitzV J Kidd
Aug 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T U KrohneL Mohr

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.